Skip to Content
Full Title A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreas (Algenpantucel-L) Immunotherapy in Subjects With Surgically Resected Pancreatic Cancer
Protocol Number NLG0405
clinicaltrials.gov http://clinicaltrials.gov/show/NCT01072981
Principal Investigator(s) Clifford S Cho, MD
Division General Surgery
Status Active, not recruiting
Description

The purpose of this study is to assess overall survival after treatment with a regimen of
adjuvant therapy (Gemcitabine alone or with 5-FU chemoradiation) with or without
HyperAcute®-Pancreas (algenpantucel-L) immunotherapy in subjects who have undergone surgical
resection.

Other Clinical Trials in the Department of Surgery
webmaster@surgery.wisc.edu Copyright © 2014 The Board of Regents of the University of Wisconsin System